If you have CML or Ph+ ALL
and you want to learn more,
you've come to the right place.
For people with chronic myeloid leukemia (CML) or Philadelphia chromosome positive acute lymphoblastic leukemia (Ph+ ALL), who cannot receive any other TKI medicines or have a T315I mutation.
Learn about CML and what you may experience with ICLUSIG.
Learn what Ph+ ALL is
and how ICLUSIG can help treat it.
Support when you need it
Takeda Oncology Support Program is here to help you access and pay for ICLUSIG, and to answer questions about treatment.LEARN MORE